To ask Her Majesty's Government what steps the Antivirals Taskforce has taken to identify suitable treatments for patients who have been exposed to COVID-19.
12 October 2021
The Antivirals Taskforce proactively develops a pipeline of priority antiviral candidates to be considered for research and procurement in the United Kingdom. The Taskforce monitors antiviral candidates at all stage of development, working collaboratively with stakeholders to identify the most promising products. In addition, the Antivirals Taskforce is contacted by a wide range of companies, academics and patients to discuss the potential suitability of antiviral products. To date, 15 companies have submitted a proposal to the Taskforce to provide more information on their product.